Surgery – Diagnostic testing – Measuring electrical impedance or conductance of body portion
Reexamination Certificate
2002-01-16
2004-10-19
Jones, Mary Beth (Department: 3736)
Surgery
Diagnostic testing
Measuring electrical impedance or conductance of body portion
C600S549000
Reexamination Certificate
active
06807444
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates generally to a medical apparatus for diagnosing tissue and methods of use, and more particularly, to a medical apparatus and methods for identifying abnormal tissue employing tissue impedance data over a range of tissue temperatures effected according to the Peltier effect for tissue diagnosis.
BACKGROUND OF THE INVENTION
Cancer and tumor are abnormal tissue that exhibits tissue characteristics different from those of the normal tissue. Among all cancer cases, breast cancer is historically the leading cause of death in women. The outlook for a wonder drug or vaccine to mitigate or cure the disease at any stage is not promising. It is known that our present methods of surgery, radiotherapy, and chemotherapy are effective for long-term survival if applied when the disease is detected early and confined locally to the lesion site.
According to a report from the National Cancer Institute (NCI), breast cancer is the most common form of cancer among women, excluding non-melanoma skin cancers. About one in eight women in the United States will develop breast cancer during her lifetime. About 192,200 women will learn they have invasive breast cancer in 2002, while 40,200 women will die from the disease. More than 85 million American women ages 20 and over are candidates for breast cancer screening. American Cancer Society and the National Comprehensive Cancer Network currently recommend annual mammograms for women identified as normal risk beginning at age 40 and for women identified as high-risk beginning at age 25.
The latest imaging techniques may detect diminutive danger signs and help recognize disease indicators during their early stage when treatment may be most beneficial. One established technique is mammography, which is used for early detection of small, treatable breast cancers. But mammography is not infallible. According to one estimate, mammography misses 10 to 15% of all malignancies. In cases where the test results are inconclusive, patients must usually undergo biopsy procedures, which can be uncomfortable and painful to patients.
This disclosure relates to a medical apparatus and methods of differentiating in a given area of tissue a tumorous tissue from a normal tissue by measuring tissue characteristics in situ across a range of tissue temperatures and comparing the measured tissue characteristics with those from reference normal healthy tissue adapted for tissue differentiation, wherein the tissue characteristics may comprise electric impedance signals, a derivative of impedance versus tissue temperature data, acoustic impedance signals and others.
It is known to measure the electrical impedance of tissue to determine aspects of tissue structure. A technique is available as “electrical impedance tomography” in which a number of impedance readings are taken at spaced apart locations on a region of the human body and an image derived from the data. Further, Brown et al. in PCT WO 01/67098 discloses a method of differentiating tissue types using impedance measurements over a range of frequencies. It has been shown that the tissue impedance decreases at higher frequencies, probably due to current penetration at the cell membrane.
Sollish et al. in U.S. Pat. No. 4,458,694, the disclosures of which are incorporated herein by reference, discloses a system in which the impedance between a point on the surface of the skin and some reference point on the body of a patient is determined. The reference prior art describes the use of a multi-element probe for the detection of cancer, especially breast cancer, utilizing detected variations of impedance in the breast. However, the skin surface impedance measurement is not site-specific for breast cancer diagnosis.
Pearlman in U.S. Pat. No. 5,810,742, No. 6,055,452, No. 6,308,097 and “New Imaging Techniques Detect Diminutive Danger Signs” by W. Leventon (MD&DI pp 48-57, October 2000), the disclosures of which are incorporated herein by reference, describe transspectral impedance scanning (T-scan) systems as a new mammography for cancer identification. The T-scan measures the movement of electricity through tissue because cancers have impedance values that are much lower than those of noncancerous tissue. It is further disclosed that the capacitance and conductance of malignant tissue are about 50 times greater than that of either normal tissue or benign lesions. However, the T-scan neither measures the site-specific minute tumor or cancer in vivo, nor manipulates the tested tissue at a range of temperatures suitable for enhancedly differentiating the impedance signal of the cancers from that of noncancerous tissue over a range of tissue temperatures.
The sonography uses high frequency sound waves to perform a wide variety of diagnostic examinations. The ultrasound frequencies typically range from about 20 kHz to above 300 MHz. The principles of diagnostic sonography rest in the tissue attenuation, reflectivity, transmission or scattering, which has been described elsewhere (C J Pavlin and F S Foster, Ultrasound Biomicroscopy of the Eye, Chapter 1, by Springer-Verlag 1995). The outer layer of an ultrasound transducer may be used as an element for impedance measurement.
Adachi et al. in U.S. Pat. No. 6,298,726, the entire contents of which are incorporated herein by reference, discloses an acoustic impedance measuring apparatus that emits ultrasonic waves to a target object and measures the acoustic impedance of the target object by ultrasonic waves fed back. The reference fails to teach manipulating the target tissue object at a range of temperatures to enhancedly differentiate the acoustic impedance signal of the cancer tissue object from that of noncancerous tissue object.
It would overcome the afore-mentioned disadvantages by providing an apparatus, such as a needle probe and a method of differentiating in a given area of tissue a tumorous tissue from a normal tissue, the method comprising measuring tissue impedance, electrically, acoustically or thermally, across a range of tissue temperatures and comparing the measured tissue impedance and/or the first impedance-temperature derivative at a tissue temperature of interest with reference counterparts of the normal tissue at same tissue temperature of interest adapted for enhanced tissue differentiation.
To maintain the tissue temperature over a range, say from 20° C. to 45° C., thermal energy and cryogenic cooling is provided selectively. Conventionally thermal energy could be clinically applied to the tissue by radiofrequency heating, while the cryogenic cooling could be provided by a circulating cooled medium in the probe. A radiofrequency probe with a liquid-cooled electrode is conventionally used to manipulate the tissue temperature over a range of clinical interest. However, such an apparatus is bulky and also cumbersome to handle the liquid cooling system. In one embodiment, the range of tissue temperatures of the present invention is about 20° C. to 45° C. that is suitable and physiologically compatible with the body tissue.
U.S. Pat. No. 5,348,554 to Imran et al. discloses a catheter system with a cooled electrode. Specifically, an electrode having a chamber therein is provided with a circulated cooling liquid to cool the electrode. U.S. Pat. No. 6,241,666 to Pomeranz et al., and U.S. Pat. No. 6,015,407 to Rieb et al. also disclose a catheter system with a modified cooled electrode, mostly with a liquid coolant arrangement that is bulky, expensive or poses unnecessary risk to a patient. The entire contents of the above-cited patents are incorporated herein by reference.
A radiofrequency catheter with a liquid-cooled electrode includes extra auxiliary equipments, such as a circulating pump, a cooling liquid source, control instruments, and accessories. As disclosed in U.S. Pat. No. 5,348,554, the cooled liquid is intended to cool the inner chamber of the tip electrode. However, the temperature of the outer surface of the electrode may rise to an unacceptable level resulting in tissue degradation, blood clot, or coagul
Quijano Rodolfo C.
Tu Hosheng
Jones Mary Beth
Kremer Matthew J
LandOfFree
Apparatus and methods for monitoring tissue impedance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apparatus and methods for monitoring tissue impedance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apparatus and methods for monitoring tissue impedance will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3313885